Research & Innovation
The King’s Centre for Lung Health is a visionary, world-class hub driving impactful respiratory research, education, and clinical translation. Our mission-driven innovation transforms fundamental discoveries into healthcare policy.

Our Four Innovation Pillars
- Unlocking Disease Pathways: We delve into fundamental mechanisms of lung diseases, from early onset to advanced stages.
- Next-Generation Diagnostics: We pioneer innovative diagnostic tools, leveraging engineering and bioengineering to create smart devices and advanced analytical platforms.
- Transformative Treatments: We design and deliver pioneering clinical trials, bringing promising therapies from ‘bench to bed’.
- Global Impact & Preparedness: Our research contributes to a deeper understanding of lung health in diverse populations and enables preparedness for future health crises.
Asthma & Allergy
COPD
Infection & Defence
Structural & Fibrotic (ILD/Cough)
Sleep & Ventilation
Immunobiology (T-cells, Tregs, Eosinophils)
Molecular Genetics (Epigenetics & Biomarkers)
Cellular Interactions (Platelets & Neutrophils)
Tissue Engineering (Organogenesis & Repair)
Our International Collaborators:

|
China - Beijing, Shanghai, Hong Kong
|
Australia - Perth
|
Belgium - Leuven
|
|
France - Paris
|
Italy - Rome
|
Spain - Barcelona, Granada
|
|
Netherlands - Amsterdam, Maastricht
|
Turkey - Istanbul
|
Portugal - Lisbon
|
|
UAE - Dubai, Abu Dhabi
|
UK - UCL, Leciester, ICL, Southampton, Nottingham, Oxford, Manchester, Hull, Northumbria, Cardiff, Cambridge
|